|Last Price$79.58||Day Change (%)-0.43%|
|Open Price$81.21||Day Change ($)-0.34|
|Day Range77.81–81.35||52-Week Range43.78–84.88|
As of Fri 03/07/2014 08:02 PM EST | USD
Gilead Prices $4 Billion of Senior Unsecured Notes
Ladies and gentlemen, thank you for standing by and welcome to the Gilead Sciences Fourth Quarter 2013 Earnings Conference Call. My name is Patrick and I'll be your conference operator today. At this time, all participants are in a listen-only mode. As a reminder, this conference call is being ...
UPDATE: Nasdaq breaks out, S&P 500 nears major -3-
UPDATE: Nasdaq breaks out, S&P 500 nears major -5-
UPDATE: Nasdaq breaks out, S&P 500 nears major -2-
UPDATE: Nasdaq breaks out, S&P 500 nears major -4-
StockInvestor editor Matt Coffina and senior biotech analyst Karen Andersen discuss Gilead's growing competitive advantages.
We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.